Women Health Diagnostics Market Share

Regionally, the global women health diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is anticipated to hold largest revenue share by 2036, impelled by large patient pool, and surging improvements in the healthcare infrastructure.

North America Market Analysis

Moreover, the women health diagnostics market in North America is expected to grab the largest share during the forecast period, which can be credited primarily to the growing occurrence of cancer among women in the region. As per the National Cancer Institute, the rate of new cases of female breast cancer in the United States was 129.1 per 100,000 women per year. The rate is age-adjusted and based on 2014–2018 cases and 2015–2019 deaths. In addition, increasing demand for fertility test monitors, and high emphasis of pharmaceutical manufacturers on expanding their presence are also predicted to bolster the growth of the market in the region in the coming years.

Frequently Asked Questions (FAQ)

The major factors driving market growth are rising awareness levels about various health disorders globally, and increasing prevalence of lifestyle and chronic diseases among women.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2022-2031.

High cost of diagnostic imaging procedures and systems is estimated to hamper the market growth.

Asia Pacific will provide more business opportunities for market growth owing to the large patient pool, and surging improvement of the healthcare infrastructure in the region.

The major players in the market are Siemens AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., General Electric Company, Hologic, Inc., and others.

Women Health Diagnostics Market Share